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Introduction
Acromegaly is a chronic, rare hormonal disease associated 
with major cardiovascular co-morbidities, and it is caused 
by a benign human growth hormone (hGH) secreting 
adenoma in the majority of the cases (1). High serum levels 
of hGH entail elevated insulin-like growth factor-1 (IGF-
1) serum concentration thus causing a wide range of clinical 
symptoms and co-morbidities (2). The most important 
ones are cardiovascular changes including left ventricular 
(LV) hypertrophy, hypertension (HT), serious valvular 
regurgitations and LV systolic and diastolic dysfunction 
at the end-stage disease. The proper mechanism of these 
changes are not clearly understood currently, it seems that 
acromegaly at end-stages results in a severe, specific type 
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of cardiomyopathy due to extracellular collagen deposition 
entailing myocardial fibrosis (3-5).
Three-dimensional speckle-tracking echocardiography 
(3DSTE) offers clinicians a new, robust, non-invasive tool 
for chamber quantification and functional assessment (6). 
Through strain imaging, 3DSTE is capable of simultaneous 
and accurate measurement of several global and segmental 
strain values (7-11). To the best of the authors knowledge, 
the right atrium (RA) has not been examined before in 
acromegaly using speckle-tracking methodology. Therefore, 
it was set out to quantify RA morphology and function in a 
group of acromegalic patients using 3DSTE.
Methods
Patient population
The study comprised 30 patients from which 8 patients 
were excluded due to inadequate image quality. Mean age of 
the remaining 22 acromegaly patients were 53.7±14.5 years 
(7 males). In the control group 44 healthy adults were 
enrolled (mean age: 50.7±12.6 years, 15 males). The 
acromegaly diagnosis was based on the current accepted 
standards: typical clinical features, elevated hGH levels 
and elevated IGF-1 serum concentration unsupressible 
by oral glucose tolerance test (5). Based on the activity 
of acromegaly, the patient population was further 
divided. The activity of the disease was judged by an 
expert endocrinologist based on current guidelines: in 
those patients who had elevated serum hGH and IGF-
1 concentration level above the diagnostic threshold 
and high IGF-1 index acromegaly was considered to be 
active. The present study is part of the MAGYAR-Path 
Study (Motion Analysis of the heart and Great vessels bY 
three-dimensionAl speckle-tRacking echocardiography in 
Pathological cases), which were created to assess diagnostic 
and prognostic value of 3DSTE-derived parameters 
(‘magyar’ means ‘Hungarian’ in Hungarian language). The 
MAGYAR-Path Study was approved by the human research 
committee of our institution and complied with the 
Declaration of Helsinki. All patients gave informed consent.
Two-dimensional doppler and tissue doppler echocardiography
C o m p l e t e  t w o - d i m e n s i o n a l  ( 2 D )  t r a n s t h o r a c i c 
echocardiography and 2D Doppler study were performed 
on all acromegaly patients and healthy controls using a 
Toshiba ArtidaTM imaging system (Toshiba Medical Systems, 
Tokyo, Japan) with a PST-30SBP (1–5 MHz) phased-
array transducer. Chamber quantification and functional 
assessment were performed according to the current clinical 
standards (12).
Three-dimensional speckle-tracking echocardiography
3DSTE measurements were carried out using the same 
Toshiba ArtidaTM system with a PST-25SX matrix-array 
transducer (Toshiba Medical Systems, Tokyo, Japan). 
During a single breath-hold, six wedge-shaped subvolumes 
were obtained in the course of six constant RR intervals. 
These subvolumes were then automatically compiled into 
a pyramid-shaped full volume 3D dataset. To enhance 
spatial resolution and border detection all datasets were 
obtained in a focused view. Data analysis was performed 
offline using 3D Wall Motion Tracking software (version 
2.7, Toshiba Medical Systems, Tokyo, Japan). The software 
automatically reconstructed the apical four-chamber 
(AP4CH) and two-chamber (AP2CH) views. Three cross-
sectional planes then had to be specified by the reader using 
the software-supplied guide planes. After the planes were 
set up, the reader manually detected the right atrial (RA) 
endocardium using 6–8 datapoints from the lateral tricuspid 
annulus to the medial tricuspid annulus. The software using 
the specified planes and datapoints performed the speckle-
tracking analysis on the 3D cast of the RA (7-10) (Figure 1). 
3DSTE-derived RA volumetric- and functional parameters
3DSTE is capable of measuring numerous volumetric and 
functional RA parameters (Figure 1): 
• End-systolic maximum RA volume (Vmax, before 
tricuspid valve opening);
• RA volume before atrial contraction (VpreA, at the time 
of the P-wave on the ECG);
• End-diastolic minimum RA volume (Vmin, before 
tricuspid valve closure).
The acquired volumetric data then can be used to 
calculate RA functional properties representing RA 
reservoir, conduit and active contraction functions (7-11):
Reservoir function:
• Total stroke volume (SV) = Vmax − Vmin
• Total emptying fraction (EF) = Total SV/Vmax
Conduit function:
• Passive SV = Vmax − VpreA
• Passive EF = Passive SV/Vmax
Active contraction:
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Figure 1 Apical four-chamber (A) and two-chamber views (B) as well as short-axis views at the basal (C1), mid- (C2), and superior (C3) 
right atrial level derived from an active acromegaly patient’s three-dimensional echocardiographic dataset. A three-dimensional cast of the 
right atrium (D) and corresponding volumetric data (E) during the cardiac cycle together with time-segmental strain curves of all right 
atrial segments and time–volume changes during the cardiac cycle (F) are also presented. The yellow arrow represents peak strain, while the 
dashed arrow represents strain at atrial contraction. Vmax, Vmin, and VpreA represent systolic maximum and diastolic minimum right atrial 
volumes and right atrial volume before atrial contraction, respectively. LV, left ventricle; RV, right ventricle; RA, right atrium.
• Active SV = VpreA − Vmin
• Active EF = Active SV/VpreA
3DSTE-derived RA strain assessments
Using the same 3DSTE-derived RA model, the software is 
capable of obtaining several linear [radial (RS), longitudinal 
(LS) and circumferential (CS)] and complex [3D (3DS) 
and area (AS)] RA strains automatically. Based on the 
measurements not only regional strains were assessed but 
also global and mean segmental strains were calculated as 
well. Peak RA strains were measured during RA reservoir 
phase at LV end-systole, and strains at atrial contraction were 
obtained during RA systole at LV end-diastole. Strains at atrial 
contraction represent RA booster pump function (Figure 1).
Statistical analysis
Datasets are reported as mean ± standard deviation. 
Confidence interval was chosen to be 95%, thus P values 
less than 0.05 were considered statistically significant. For 
assessment of normal distribution, Shapiro-Wilks test was 
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used. Levene’s test was used to evaluate homogeneity of 
variances. Student’s two-tailed t-test was used for normally 
distributed datasets, while Mann-Whitney Wilcoxon test 
was used for datasets not following a normal distribution. 
For the assessment of categorical variables Fisher’s exact test 
was used. Pearson’s correlation coefficients were calculated 
to establish significant correlation between independent 
variables. For offline data extraction and analysis, a 
commercial software package was used (MATLAB 8.6, The 
MathWorks Inc., Natick, MA, 2015). RStudio was used for 
all statistical calculations (RStudio Team, RStudio: Integrated 
Development for R. RStudio, Inc., Boston, MA, 2015).
Results
Clinical and demographic data of patients with acromegaly
The control group was risk factor-matched as well as age- 
and gender-matched, therefore there were no significant 
differences between the acromegaly group and controls 
(Table 1). In the active acromegaly group 5 patients were 
on bromocriptine therapy and 4 patients were taking 
long-acting somatostatine analogues, also 6 patients had 
hypophysectomy previously. In the inactive acromegaly 
group 2 patients were taking bromocriptine, 3 patients were 
taking long-acting somatostatine analogues and 4 patients 
had successful hypophysectomy previously. In this group 
2 patients required hormonal substitution therapy due to 
surgery: one patient was on hydrocortisone, desmopressin, 
L-thyroxine and estradiol, and the other patient was only 
on hydrocortisone and L-thyroxine.
Laboratory findings of patients with acromegaly
Active acromegaly group consisted of 10 patients (mean age: 
Table 1 Demographic clinical data and two-dimensional echocardiographic parameters of patients with acromegaly and controls
Data Acromegaly patients (n=22) Controls (n=44) P value
Risk factors
Age (years) 53.7±14.5 50.7±12.6 0.4
Male gender [%] 7 [33] 15 [34] 0.8
Hypertension [%] 11 [50] 11 [25] 0.06
Hypercholesterolemia [%] 9 [43] 8 [18] 0.07
Diabetes mellitus [%] 3 [14] 2 [5] 0.3
Medications
β-blockers [%] 6 [29] 4 [9] 0.07
ACE-inhibitors [%] 7 [33] 6 [14] 0.1
ARB [%] 4 [19] 2 [5] 0.09
Diuretics [%] 7 [33] 5 [11] 0.09
Two-dimensional echocardiography
LA diameter (mm) 42.4±6.6 37.9±4.4 0.009
LV end-diastolic diameter (mm) 50.6±4.3 48.0±3.6 0.03
LV end-diastolic volume (mL) 124.7±23.4 106.7±20.4 0.005
LV end-systolic diameter (mm) 30.2±4.5 31.5±2.9 0.1
LV end-systolic volume (mL) 38.2±12.7 36.9±8.9 0.7
Interventricular septum (mm) 10.5±1.6 9.5±1.4 0.03
LV posterior wall (mm) 10.8±1.7 9.6±1.7 0.008
LV ejection fraction (%) 68.8±7.5 65.1±3.7 0.049
LA, left atrium; LV, left ventricle; ACE, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.
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Table 2 Comparison of 3DSTE-derived volumetric right atrial parameters of patients with acromegaly and controls
Data Controls (n=44)
Acromegaly patients 
(n=22)
Active acromegaly 
patients (n=10)
Inactive acromegaly patients 
(n=12)
Calculated volumes (mL)
Vmax 47.2±13.5 54.5±14.4* 53.9±10.7 55.1±17.3
Vmin 28.7±9.8 35.5±10.2* 36.0±9.2* 35.1±11.2
VpreA 37.9±11.7 45.1±11.1* 45.7±8.5* 44.6±13.2
Stroke volumes (mL)
TASV 18.5±8.9 19.0±8.1 17.8±4.7 19.9±10.3
PASV 9.3±6.4 9.4±6.2 8.2±4.7 10.4±7.3
AASV 9.2±5.3 9.6±4.8 9.6±3.6 9.5±5.8
Emptying fractions (%)
TAEF 38.6±13.1 34.5±9.9 33.5±7.8 35.3±11.6
PAEF 19.3±10.7 16.7±8.8 14.9±7.0 18.2±10.1
AAEF 24.2±11.1 21.2±9.5 21.7±8.3 20.8±10.8
*, P<0.05 vs. controls; †, P<0.05 vs. active acromegaly group. Vmax, maximum left atrial volume; Vmin, minimum left atrial volume; VpreA, 
left atrial volume before atrial contraction; TASV, total atrial stroke volume; TAEF, total atrial emptying fraction; AASV, active atrial stroke 
volume; AAEF, active atrial emptying fraction; PASV, passive atrial stroke volume; PAEF, passive atrial emptying fraction.
58.3±12.4 years, 4 males). Their mean serum level of hGH 
was 5.5±4.0 ng/mL, IGF-1 level was 430.9 ±216.0 ng/mL 
and IGF-1 index was 1.8±1.0. In this group, hypophysectomy 
was performed in 6 cases (60%). The inactive disease group 
consisted of 12 patients (mean age: 49.9±15.5 years, 3 males). 
Their mean serum level of hGH was 5.2±8.2 ng/mL, IGF-1 
level was 227.3±96.1 ng/mL and IGF-1 index was 1.2±1.1. In 
this group, hypophysectomy was performed in 4 cases (33%).
Two-dimensional echocardiographic data
Between the acromegaly group and healthy controls LA 
diameter (P=0.009), LV end-diastolic diameter (P=0.03) 
and volume (P=0.005) were significantly different. In case 
of acromegaly, both LV interventricular septum (P=0.03) 
and LV posterior wall (P=0.008) were significantly thicker 
compared to healthy controls and LV ejection fraction 
(P=0.049) was significantly higher in case of the acromegaly 
group as well (Table 1).
3DSTE-derived volumes and volume-based RA functional 
properties
All three RA volumetric parameters (Vmax, Vmin, VpreA) 
were significantly higher in case of acromegaly compared 
to the healthy controls (P=0.03, P=0.009 and P=0.005, 
respectively). RA stroke volumes and emptying fractions 
were not significantly different compared to the control 
group. In case of active acromegaly, both Vmin (P=0.02) 
and VpreA (P=0.01) were significantly higher compared to 
the control group. In case of the other RA volume-derived 
functional properties, there was no significant difference 
between active disease and controls. The inactive disease 
group showed no significant difference compared to the 
healthy controls, also no significant differences could be 
detected between active and inactive acromegaly subgroups 
regarding RA volumetric and volume-based functional 
parameters (Table 2).
3DSTE-derived RA peak strain parameters
Both global and mean segmental 3DS were higher in the 
acromegaly group compared to the controls (P=0.03 and 
P=0.04, respectively), also mean segmental CS proved to 
be significantly lower in case of acromegaly (P=0.03). Out 
of the segmental strains, midatrial 3DS was significantly 
higher compared to the controls (P=0.04). Regarding global 
and mean segmental strains, the active acromegaly group 
showed significantly lower mean segmental LS (P=0.009) 
compared to the controls, moreover it is worthy to note 
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that global and mean segmental 3DS were tendentiously 
higher, while global LS, global and mean segmental AS 
were tendentiously lower compared to the healthy controls. 
In the active acromegaly group there were no significant 
differences in case of peak regional RA strains compared to 
the control group. In the inactive acromegaly group, there 
were no significant differences compared to the controls 
regarding global and mean segmental RA peak strains, 
however global and mean segmental RS, and 3DS were 
tendentiously higher, where global and mean segmental AS 
were lower compared to the healthy controls. Midatrial 3DS 
(P=0.03) was significantly higher in the inactive acromegaly 
group as compared to the controls. Between the active and 
inactive group of acromegaly patients, mean segmental 
LS (P=0.04) was significantly different. Out of regional 
peak RA strains, midatrial LS (P=0.005) was significantly 
different between the acromegaly groups (Tables 3,4).
3DSTE-derived RA strain parameters at atrial contraction
At atrial contraction, mean segmental RS (P=0.04) and 
3DS (P=0.04) were significantly higher in the acromegaly 
group compared to the controls. Superior and midatrial 
3DS (P=0.049 and P=0.02, respectively) and midatrial RS 
(P=0.03) were significantly different out of the regional 
strains compared to the controls. In the active acromegaly 
subgroup, there were no significant differences regarding 
global and mean segmental strains compared to the healthy 
group. Out of the regional strains only the superior 3DS 
was significantly higher in the active acromegaly group 
compared to the controls (P=0.047). In the inactive 
acromegaly group, only midatrial 3DS was significantly 
higher as compared to the controls (P=0.027). The activity 
of acromegaly had no significant impact on RA strains at 
atrial contraction (Tables 5,6). 
Correlation analysis
In the acromegaly group, no 2D or 3D echocardiography-
derived parameter correlated significantly with hGH. 2D 
echocardiography-derived late transmitral flow velocity (A) 
(r=−0.454, P=0.04) and peak basal RS (r=−0.491, P=0.02) 
showed significant correlation with IGF-1 hormone levels 
in the acromegaly group. In this group, IGF-1 index 
correlated significantly with basal RS at atrial contraction 
(r=−0.569, P=0.007), superior RS at atrial contraction 
(r=−0.557, P=0.009), mean segmental RS at atrial 
contraction (r=−0.523, P=0.02), peak basal 3DS (r=−0.497, 
P=0.02), peak mean segmental 3DS (r=−0.443, P=0.04), 
basal 3DS at atrial contraction (r=−0.492, P=0.02), superior 
3DS at atrial contraction (r=−0.502, P=0.02) and mean 
segmental 3DS at atrial contraction (r=−0.447, P=0.04). 
In the active acromegaly subgroup, hGH correlated 
significantly with peak basal LS (r=−0.683, P=0.03), peak 
Table 3 Comparison of 3DSTE-derived global and mean segmental peak right atrial strain parameters in patients with acromegaly and controls
Data Controls (n=44) Acromegaly patients (n=22) Active acromegaly patients (n=10) Inactive acromegaly patients (n=12)
Global strains
Radial (%) −17.19±8.30 −20.07±8.36 −18.92±9.93 −21.03±7.10
Circumferential (%) 15.79±9.81 11.59±9.81 11.90±7.67 11.34±11.64
Longitudinal (%) 31.21±14.17 28.93±8.88 24.86±4.37 32.32±10.36
3D (%) −7.88±4.80 −11.94±7.52* −11.72±7.43 −12.13±7.91
Area (%) 49.43±27.05 38.99±16.30 37.18±13.44 40.50±18.82
Mean segmental strains
Radial (%) −21.45±7.44 −24.09±7.06 −23.69±8.14 −24.42±6.37
Circumferential (%) 22.14±10.61 16.77±9.45* 17.25±8.10 16.37±10.79
Longitudinal (%) 35.30±13.88 32.08±8.57 28.17±4.89* 35.34±9.75†
3D (%) −13.61±5.08 −17.16±6.13* −17.47±6.64 −16.91±5.96
Area (%) 58.58±29.13 46.21±15.51 43.88±14.67 48.15±16.56
*, P<0.05 vs. controls; †, P<0.05 vs. active acromegaly group. 3D, three-dimensional.
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Table 4 Comparison of 3DSTE-derived regional peak right atrial strain parameters in patients with acromegaly and controls 
Data Controls (n=44) Acromegaly patients (n=22) Active acromegaly patients (n=10) Inactive acromegaly patients (n=12)
RSbasal (%) −20.66±7.74 −22.77±8.13 −25.36±8.99 −20.61±6.98
RSmidatrial (%) −20.66±9.26 −23.39±8.41 −21.27±8.55 −25.16±8.25
RSsuperior (%) −23.79±12.89 −27.11±11.8 −24.80±13.30 −29.03±10.59
CSbasal %) 24.21±13.79 17.85±8.98 18.39±9.46 17.41±8.96
CSmidatrial (%) 19.25±9.05 15.18±8.95 15.53±7.79 14.88±10.15
CSsuperior (%) 23.11±20.29 17.54±17.38 18.12±13.51 17.06±20.66
LSbasal (%) 36.27±20.87 33.44±15.22 30.91±8.81 35.55±19.19
LSmidatrial %) 44.92±20.34 42.24±13.43 34.05±6.23 49.06±14.17
†
LSsuperior (%) 19.40±11.33 14.80±9.92 15.23±9.39 14.44±10.74
3DSbasal (%) −13.16±5.89 −15.80±7.55 −17.88±7.31 −14.07±7.61
3DSmidatrial (%) −11.78±5.78 −15.39±5.31* −14.58±5.82 −16.07±5.00*
3DSsuperior %) −17.04±10.59 −21.87±10.82 −21.20±12.22 −22.43±10.03
ASbasal (%) 53.99±38.30 42.92±19.07 44.91±19.27 41.26±19.59
ASmidatrial (%) 67.88±32.08 56.50±19.12 48.29±14.78 63.33±20.17
ASsuperior (%) 51.54±47.45 35.71±36.72 35.72±28.54 35.71±43.67
*, P<0.05 vs. controls; †, P<0.05 vs. active acromegaly group. RS, radial strain; CS, circumferential strain; LS, longitudinal strain; 3DS, 
three-dimensional strain; AS, area strain.
Table 5 Comparison of 3DSTE-derived global and mean segmental right atrial strain parameters at atrial contraction in patients with acromegaly 
and controls
Data Controls (n=44)
Acromegaly patients 
(n=22)
Active acromegaly 
patients (n=10)
Inactive acromegaly patients 
(n=12)
Global strains
Radial (%) −7.34±6.11 −10.60±8.15 −12.44±9.08 −9.07±7.33
Circumferential (%) 10.24±9.05 6.44±7.44 7.34±7.31 5.70±7.79
Longitudinal (%) 7.59±6.45 8.44±5.82 10.05±6.78 7.09±4.76
3D (%) −4.00±3.76 −6.40±7.10 −8.11±7.62 −4.97±6.61
Area (%) 18.11±17.29 18.73±17.69 21.01±18.67 16.83±17.43
Mean segmental strains
Radial (%) −9.65±4.41 −13.22±6.45* −14.74±7.25 −11.96±5.71
Circumferential (%) 11.15±7.41 9.08±6.18 10.36±6.50 8.01±5.96
Longitudinal (%) 10.63±5.81 11.35±5.13 13.52±6.30 9.55±3.15
3D (%) −6.70±3.58 −9.78±5.44* −10.74±5.68 −8.98±5.35
Area (%) 21.73±13.83 22.19±12.47 25.27±14.80 99.62±10.10
*, P<0.05 vs. controls. 3D, three-dimensional.
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Table 6 Comparison of 3DSTE-derived regional right atrial strain parameters at atrial contraction in patients with acromegaly and controls
Data Controls (n=44)
Acromegaly patients 
(n=22)
Active acromegaly 
patients (n=10)
Inactive acromegaly 
patients (n=12)
RSbasal (%) −10.25±5.59 −13.14±7.20 −15.87 ±7.71 −10.86±6.15
RSmidatrial (%) −8.87±4.95 −12.57±6.99* −13.07±7.62 −12.16±6.74
RSsuperior (%) −9.93±7.52 −14.32±9.02 −15.55±11.07 −13.30±7.25
CSbasal %) 12.11±8.20 9.19±7.44 9.88±6.82 8.61±8.17
CSmidatrial (%) 10.22±6.96 8.15±5.14 8.83±5.82 7.58±4.70
CSsuperior (%) 10.07±11.11 10.31±11.53 13.39±11.95 7.73±11.01
LSbasal (%) 10.73±7.09 9.85±6.02 12.42±6.88 7.70±4.42
LSmidatrial %) 12.04±6.95 14.85±7.56 16.85±9.11 13.18±5.86
LSsuperior (%) 8.41±8.64 8.36±6.99 10.16±7.61 6.87±6.38
3DSbasal (%) −6.85±4.85 −8.56±5.62 −10.30±5.49 −7.11±5.53
3DSmidatrial (%) −5.81±3.70 −9.20±5.95* −9.22±6.61 −9.19±5.64*
3DSsuperior %) −7.80±7.06 −12.47±8.07* −13.68±9.17* −11.46±7.28
ASbasal (%) 21.08±11.99 18.50±12.25 23.33±15.52 14.49±7.11
ASmidatrial (%) 22.42±14.10 27.01±13.15 27.30±13.52 26.76±13.42
ASsuperior (%) 21.65±26.05 20.48±24.04 25.15±24.32 16.59±24.14
*, P<0.05 vs. controls. RS, radial strain; CS, circumferential strain; LS, longitudinal strain; 3DS, three-dimensional strain; AS, area strain.
global LS (r=−0.690, P=0.03) and global LS at atrial 
contraction (r=−0.656, P=0.04). IGF-1 hormone levels 
in the active acromegaly group correlated significantly 
with peak basal RS (r=−0.707, P=0.04), mean segmental 
basal RS (r=−0.654, P=0.04), basal RS at atrial contraction 
(r=−0.654, P=0.04), superior RS at atrial contraction 
(r=−0.654, P=0.04), global RS at atrial contraction (r=−0.732, 
P=0.02), mean segmental RS at atrial contraction (r=−0.741, 
P=0.01), peak midatrial CS (r=0.680, P=0.03), peak global 
CS (r=0.672, P=0.03), peak mean segmental CS (r=0.638, 
P=0.047), basal CS at atrial contraction (r=0.643, P=0.045), 
midatrial CS at atrial contraction (r=0.819, P=0.004), global 
CS at atrial contraction (r=0.705, P=0.02), mean segmental 
CS at atrial contraction (r=0.713, P=0.02), global LS at 
atrial contraction (r=0.722, P=0.02), superior 3DS at atrial 
contraction (r=−0.651, P=0.04), peak basal AS (r=0.687, 
P=0.03), peak mean segmental AS (r=0.690, P=0.03), basal 
AS at atrial contraction (r=0.784, P=0.007), midatrial AS at 
atrial contraction (r=0.650, P=0.04) and mean segmental 
AS at atrial contraction (r=0.738, P=0.02). IGF-1 index 
correlated significantly in the active disease group with 
peak basal RS (r=−0.648, P=0.04), peak mean segmental RS 
(r=−0.671, P=0.03), basal RS at atrial contraction (r=−0.635, 
P=0.049), midatrial RS at atrial contraction (r=−0.642, 
P=0.045), superior RS at atrial contraction (r=−0.712, 
P=0.02), global RS at atrial contraction (r=−0.801, P=0.005), 
mean segmental RS at atrial contraction (r=−0.778, 
P=0.008), peak midatrial CS (r=0.672, P=0.03), peak global 
CS (r=0.643, P=0.045), midatrial CS at atrial contraction 
(r=0.795, P=0.006), mean segmental CS at atrial contraction 
(r=0.675, P=0.03), basal LS at atrial contraction (r=0.634, 
P=0.049), global LS at atrial contraction (r=0.743, P=0.01), 
superior 3DS at atrial strain (r=−0.711, P=0.021), mean 
segmental 3DS at atrial contraction (r=-0.633, P=0.049), 
peak basal AS (r=0.666, P=0.04), peak mean segmental AS 
(r=0.666, P=0.04), basal AS at atrial contraction (r=0.775, 
P=0.009) and mean segmental AS at atrial contraction 
(r=0.686, P=0.03). In the inactive acromegaly group, 
hGH had no significant correlation with any independent 
variables. In this group, IGF-1 correlated significantly with 
2D LV ESD (r=0.657, P=0.03) and 2D LV ESV (r=0.675, 
P=0.02). In the inactive disease group, IGF-1 index 
correlated significantly with 2D LV ESD (r=0.645, P=0.03) 
and 2D LV ESV (r=0.660, P=0.03).
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Discussion
Acromegaly is a relatively rare, hormonal, chronic disease 
involving several organs through elevated hGH and IGF-
1 levels (13). Cardiovascular involvement is especially 
common in acromegalic patients, from the most common 
hypertension to cardiomyopathy (14). Pathophysiology 
of these cardiac co-morbidities is not clearly understood, 
although studies show that acromegaly entails a specific 
type of cardiomyopathy, which might result in severe heart 
failure at end-stages. In the early stages of the disease, 
LV hypertrophy develops due to hyperkinetic syndrome 
and as the disease progresses, collagen deposition begins. 
This extracellular collagen causes at first diastolic and 
later systolic heart failure. At end-stages, congestive heart 
failure develops combined with valvular insufficiencies and 
increased incidence of arrhythmias (atrial fibrillation is 
the most common). The hyperkinetic syndrome is caused 
by hGH and IGF-1 mediated Ca2+ hypersensitivity and 
reduced peripheral vascular resistance at the beginning 
(15-21). Furthermore, elevated hormone levels cause 
sodium retention and subsequent plasma expansion 
resulting in circulatory volume increase (22-24). To the 
best of the author’s knowledge there are no 3DSTE studies 
examining the effect of acromegaly treatment on RA 
function, however Heidarpour et al. recently published 
a systematic review on the effect of somatostatin analog 
treatment on cardiovascular parameters in acromegaly. 
According to this study heart rate and left ventricular mass 
index decreased significantly after treatment, and E/A ratio 
improved significantly in a few studies, as well (25).
There are emerging, new echocardiographic techniques 
such as 3D echocardiography and/or STE. These modalities 
are capable of not only assessing the LV but also the atria 
using a “block-matching” by strain analysis algorithm. 
Volumetric real-time 3D echocardiography (RT3DE) is 
widely regarded as a non-invasive, accurate tool for the 
volumetric and volume-derived functional assessment of 
the atria (7-10). In previous studies, 3DSTE was found to 
be comparable and interchangeable to RT3DE (26). Our 
group has also demonstrated that 3DSTE is a feasible tool 
in volumetric and strain imaging of RA previously (7-10).
RA has a distinct phasing function throughout the 
cardiac cycle. During RV systole, it functions as a reservoir, 
during early RV diastole, RA conducts the blood from 
the caval veins to the RV, and lastly in late RV diastole, 
RA contractions act as a booster pump to RV filling (11). 
Total, passive and active SVs and EFs correspond to these 
phasic functions. The complete 3DSTE datasets gave us the 
possibility to not only characterize RA function by volume 
and volume-derived functional parameters but to assess 
global, mean segmental and regional peak strains and strains 
at atrial contraction at the same time, as well.
To the best of the author’s knowledge, there are no 
studies characterizing RA volumes, volume-based functional 
properties and strains at the same time in acromegaly patients 
using 3DSTE. However, our group previously demonstrated 
that aortic stiffness is increased in acromegaly (27) with its 
prognostic value (28). LV twist was found to be impaired 
in acromegaly regardless of disease activity (29) and most 
importantly, LA function was found to be similarly enhanced 
in case of active acromegaly (30).
The data presented in this study suggests profound 
RA remodellation, especially in active acromegaly as 
compared to the healthy group. Furthermore, strain 
analysis revealed that RA function may be enhanced in 
acromegalic patients, which is more notable in case of 
active disease. Correlation analysis revealed that numerous 
independent strain parameters had significant correlations 
with different hormonal variables in the active acromegaly 
group. These correlations were not present in the inactive 
acromegaly subgroup however. These results suggest that 
RA remodellation and functional changes may subside 
with proper treatment of the disease. These changes 
may be reactive to the LV and LA dysfunction that are 
characteristic in acromegaly. However, collagen deposition 
cannot be ruled out as it affects the whole heart not only the 
LV, thus causing parallel RA remodellation as well, similarly 
to LA and LV remodellation. The real mechanism involved 
is not completely understood yet at present, however RV 
remodellation might have a direct effect on RA changes. 
As of yet there are no studies characterizing RV changes in 
acromegaly or confirming whether RV behaves in the same 
manner as LV in this disease, thus resulting in impaired 
RV filling entailing RA enlargement and subsequent 
remodellation. These questions warrant further studies in 
this field.
Limitations
There are numerous limiting factors of the present study, 
mainly the relatively low number of patients involved. The 
duration of acromegaly/inactivity of acromegaly or the 
effect of drugs were not investigated. Currently there are 
no reference values for RA strains, therefore the reported 
strains of our control group might differ compared to other 
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articles. There are several technical limiting factors as well, 
such as the relatively low spatial and temporal resolution of 
current 3DSTE methodologies. Full volume datasets are 
acquired through 6 RR intervals and this might cause so 
called “stitching noise” (31). 
Conclusions
Acromegaly has a profound effect on RA function and 
with proper treatment, these changes partly seem to be 
reversible.
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